Digital chronic-care leader Omada Health is set to begin prescribing GLP-1 weight-loss drugs nationwide in 2026, marking a major expansion…
Browsing: Clinical Updates
New research from IRB Barcelona and CNAG uncovers how colorectal tumors build a powerful two-layer defense that shields them from…
Obesity is a chronic, relapsing disease with significant health and economic impacts. As obesity rates and new medication options rise,…
CapsoVision has filed for FDA Breakthrough Device Designation for its CapsoCam UGI capsule endoscopy system — a swallowable camera designed…
Fresh from ACG 2025, Dr. David Johnson spotlights four studies poised to reshape GI practice — from colonoscopy quality to…
Even among top-tier gastroenterologists, how to best manage Barrett esophagus remains unsettled. A new Mayo Clinic–led survey of BE experts…
October marked a breakthrough month for gastroenterology — one defined by fresh FDA approvals, promising IBD trial data, and pivotal…
Starting Jan. 1, 2026, Medicare will reduce payments for GI endoscopy services in ASCs by about 8%, while boosting reimbursement…
In a landmark move, the U.S. FDA has approved Linzess (linaclotide) for pediatric patients aged 7 years and above with…
At the ACG 2025 Annual Meeting, researchers from Boston Medical Center revealed that targeted education and workflow changes between emergency…